Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 52 min ago

RAPID MICRO BIOSYSTEMS, INC.: Longitude Capital Partners II, LLC amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Longitude Capital Partners II, LLC amended its Schedule 13G filing on Rapid Micro Biosystems, Inc., updating its beneficial ownership stake with the SEC under accession number 0001193125-26-464016. The filing reflects a change in the investor's reported position in the microbiology diagnostics company. The amendment signals a shift in Longitude's holdings, which matters to investors tracking institutional ownership and potential influence over corporate strategy. Specific share counts and percentage figures were not disclosed in the filing summary. What to watch next is whether the amended stake reflects accumulation or reduction, and how other institutional holders respond.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Longitude Capital Partners II, LLC, Rapid Micro Biosystems, Inc.